14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ONCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Oncolytics Biotech Inc. stock price down 0% on Friday
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 25, 2024 Gain 8.33% PDF

No changes to the price of Oncolytics Biotech Inc. stock on the last trading day (Friday, 3rd May 2024). During the last trading day the stock fluctuated 2.59% from a day low at $1.16 to a day high of $1.19. The price has risen in 6 of the last 10 days and is up by 10.38% over the past 2 weeks.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.21 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 5.02% during the next 3 months and, with a 90% probability hold a price between $1.00 and $1.27 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ONCY Signals & Forecast

The Oncolytics Biotech Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.12 and $1.08. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Oncolytics Biotech Inc. stock

Oncolytics Biotech Inc. finds support from accumulated volume at $1.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0300 between high and low, or 2.59%. For the last week the stock has had daily average volatility of 3.90%.

Our recommended stop-loss: $1.13 (-3.56%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ONCY) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Oncolytics Biotech Inc. to open at $1.17, and during the day (based on 14 day Average True Range), to move between $1.11 and $1.23, which gives a possible trading interval of +/-$0.0571 (+/-4.88%) up or down from last closing price. If Oncolytics Biotech Inc. takes out the full calculated possible swing range there will be an estimated 9.77% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.15, some $0.0200 (1.71%) from the current price of $1.17, our system finds the risk reward attractive.

Earnings coming up

Oncolytics Biotech Inc. will release earnings AMC on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0900. We will update the financials statements for Oncolytics Biotech Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.44% in the first trading day after earnings release.

Is Oncolytics Biotech Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Oncolytics Biotech Inc. stock to perform well in the short-term.

Current score: 2.001 Buy Candidate Unchanged

Predicted Opening Price for Oncolytics Biotech Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.17 ( 0.285%) $1.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ONCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.20 2.85 %
R2 1.19 1.87 %
R1 1.18 1.26 %
Current price: 1.17
Support S1 1.16 -0.695 %
S2 1.15 -1.30 %
S3 1.14 -2.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.17
Support S1 1.15 -1.71%
S2 1.05 -10.26%
S3 1.02 -12.82%

FAQ

What is the symbol for Oncolytics Biotech Inc. Stock and on which exchange is it traded?
The symbol for Oncolytics Biotech Inc. is ONCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oncolytics Biotech Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Oncolytics Biotech Inc. stock to perform well in the short-term.

How to buy Oncolytics Biotech Inc. Stock?
Oncolytics Biotech Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncolytics Biotech Inc. Stock.

What's the current price of Oncolytics Biotech Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Oncolytics Biotech Inc. (ONCY) share was $1.17.

What is the 52-week high and low for Oncolytics Biotech Inc. Stock?
The 52-week high for Oncolytics Biotech Inc. Stock is $3.39 and the 52-week low is $0.89.

What is the market capitalization of Oncolytics Biotech Inc. Stock?
As of the May 03, 2024, the market capitalization of Oncolytics Biotech Inc. is 88.241M.

When is the next earnings date for Oncolytics Biotech Inc.?
The upcoming earnings date for Oncolytics Biotech Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Oncolytics Biotech Inc.

Oncolytics Biotech. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with ... ONCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT